drugset / Trial / NCT00130949

ALGRX 4975 in the Treatment of Tennis Elbow

NCT00130949

Phase 2 Completed 45 enrolled AlgoRx Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

Tennis elbow is a painful condition that results from repetitive arm movement with overuse of muscles, e.g. when playing tennis. A single injection of ALGRX 4975 has the potential to reduce pain for a period of weeks to months. This study will test the efficacy and safety of ALGRX 4975 in the treatment of patients with tennis elbow.

Timeline

Start
2004-11
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 100 ug Other

Indications